MY130800A - Process for preparing trovafloxacin acid salts - Google Patents

Process for preparing trovafloxacin acid salts

Info

Publication number
MY130800A
MY130800A MYPI99003775A MYPI9903775A MY130800A MY 130800 A MY130800 A MY 130800A MY PI99003775 A MYPI99003775 A MY PI99003775A MY PI9903775 A MYPI9903775 A MY PI9903775A MY 130800 A MY130800 A MY 130800A
Authority
MY
Malaysia
Prior art keywords
acid
acid salts
trovafloxacin
salts
trovafloxacin acid
Prior art date
Application number
MYPI99003775A
Other languages
English (en)
Inventor
Timothy Norris
Peter Robert Rose
Keith Michael De Vries
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of MY130800A publication Critical patent/MY130800A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cephalosporin Compounds (AREA)
  • Indole Compounds (AREA)
  • Peptides Or Proteins (AREA)
MYPI99003775A 1998-09-03 1999-09-01 Process for preparing trovafloxacin acid salts MY130800A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9894498P 1998-09-03 1998-09-03

Publications (1)

Publication Number Publication Date
MY130800A true MY130800A (en) 2007-07-31

Family

ID=22271674

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI99003775A MY130800A (en) 1998-09-03 1999-09-01 Process for preparing trovafloxacin acid salts

Country Status (40)

Country Link
US (1) US6359137B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0989119A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JP3354526B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR20000022858A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CN (1) CN1248580A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AP (1) AP1118A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AR (1) AR021475A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU761035B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BG (1) BG103703A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BR (1) BR9904082A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA2281244C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CO (1) CO5251466A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EA (1) EA002340B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EE (1) EE04118B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GE (1) GEP20022785B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GT (1) GT199900142A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HN (1) HN1999000141A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HR (1) HRP990274A2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HUP9902967A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ID (1) ID23718A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL131614A0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IN (1) IN191583B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IS (1) IS5168A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MA (1) MA24966A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MY (1) MY130800A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO994261L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ337605A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
OA (1) OA11152A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PA (1) PA8481001A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PE (1) PE20001026A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PL (1) PL335246A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SG (1) SG74748A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SK (1) SK116599A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SV (1) SV1999000144A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
TN (1) TNSN99164A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
TR (1) TR199902138A2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
TW (1) TW520369B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
UY (1) UY25686A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
YU (1) YU43199A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA995630B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104892507B (zh) * 2015-05-26 2018-08-28 徐州天意动物药业股份有限公司 水溶性甲磺酸沙拉沙星及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5164402A (en) * 1989-08-16 1992-11-17 Pfizer Inc Azabicyclo quinolone and naphthyridinone carboxylic acids
AU694149B2 (en) * 1994-01-18 1998-07-16 Pfizer Inc. Process and intermediates for preparing naphthyridonecarboxylic acid salts
WO1996039406A1 (en) * 1995-06-06 1996-12-12 Pfizer Inc. NOVEL CRYSTAL FORM OF ANHYDROUS 7-([1α, 5α, 6α]-6-AMINO-3-AZABICYCLO[3.1.0]HEX-3-YL)-6-FLUORO-1-(2,4-DIFLUOROPHENYL)-1,4-DIHYDRO-4-OXO-1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACID, METHANESULFONIC ACID SALT
JPH0912546A (ja) * 1995-06-23 1997-01-14 Chisso Corp アザビシクロ環化合物および製造方法
JPH0912547A (ja) * 1995-06-23 1997-01-14 Chisso Corp ニューキノロン系化合物中間体の製造方法
CN1190889A (zh) * 1995-08-29 1998-08-19 美国辉瑞有限公司 曲氟沙星的两性离子形式
US6184380B1 (en) * 1999-01-25 2001-02-06 Pfizer Inc. Process for preparing naphthyridones and intermediates
PA8464701A1 (es) * 1998-01-16 2000-09-29 Pfizer Prod Inc Procedimiento e intermedios para preparar naftiridonas

Also Published As

Publication number Publication date
UY25686A1 (es) 2000-03-31
TW520369B (en) 2003-02-11
EE04118B1 (et) 2003-08-15
BR9904082A (pt) 2000-09-12
IS5168A (is) 2000-03-04
CA2281244A1 (en) 2000-03-03
HUP9902967A2 (hu) 2000-05-28
HU9902967D0 (en) 1999-10-28
SG74748A1 (en) 2000-08-22
HUP9902967A3 (en) 2000-11-28
EA002340B1 (ru) 2002-04-25
IN191583B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 2003-12-06
HRP990274A2 (en) 2000-10-31
JP2000086658A (ja) 2000-03-28
GT199900142A (es) 2001-02-15
BG103703A (bg) 2001-08-31
SK116599A3 (en) 2000-05-16
MA24966A1 (fr) 2000-04-01
EA199900708A2 (ru) 2000-04-24
NO994261D0 (no) 1999-09-02
AP9901667A0 (en) 1999-12-31
AR021475A1 (es) 2002-07-24
CA2281244C (en) 2003-05-20
PA8481001A1 (es) 2000-09-29
GEP20022785B (en) 2002-09-25
TNSN99164A1 (fr) 2005-11-10
US6359137B1 (en) 2002-03-19
CN1248580A (zh) 2000-03-29
YU43199A (sh) 2002-11-15
TR199902138A2 (xx) 2000-04-21
NZ337605A (en) 2001-03-30
EP0989119A1 (en) 2000-03-29
HN1999000141A (es) 2000-06-19
CO5251466A1 (es) 2003-02-28
EA199900708A3 (ru) 2000-08-28
ZA995630B (en) 2001-03-01
NO994261L (no) 2000-03-06
ID23718A (id) 2000-05-11
PL335246A1 (en) 2000-03-13
IL131614A0 (en) 2001-01-28
JP3354526B2 (ja) 2002-12-09
SV1999000144A (es) 2000-09-05
AU761035B2 (en) 2003-05-29
AU4482699A (en) 2000-03-16
KR20000022858A (ko) 2000-04-25
OA11152A (en) 2003-04-17
PE20001026A1 (es) 2000-10-11
AP1118A (en) 2002-11-21
EE9900457A (et) 2000-04-17

Similar Documents

Publication Publication Date Title
AP2000002011A0 (en) Method for making 4-carboxyamino-2-substituted-1,2,3,4- tetrahydroquinoline.
HU9601857D0 (en) New benzyl-piperidine- or -tetrahydro-pyridine derivatives and processes for producing them
GB0322510D0 (en) Novel compounds
UA8017A1 (uk) Спосіб отримання похідних хінолінкарбонової кислоти
PT1097130E (pt) Processo de preparacao do acido hidroximetiltiobutirico
BG105766A (en) New process for preparing pesticidal intermediates
MY130800A (en) Process for preparing trovafloxacin acid salts
MY130656A (en) Benzo [g] quinoline derivatives for treating glaucoma and myopia
IL155677A0 (en) Cyclization process step in the making of quinolones and naphthyridines
IL146811A0 (en) Novel method for preparing benzoperhydroisoindole compounds
EA200000172A2 (ru) Способ получения стимуляторов секреции гормонов роста
EA199900458A3 (ru) Способ и промежуточные продукты для получения пиридин-2,3-дикарбоксилатов
PL367114A1 (en) Process for preparing a thialzole ppar-ligand and polymorphs thereof
ATE244706T1 (de) Enantiomere von mercaptolactonen und verfahren zu ihrer herstellung
IL138638A0 (en) Processes for preparing intermediates
IL148161A0 (en) Process for the preparation of 2-cyanopyridines
PL338215A1 (en) Method of obtaining 3-cyano-2,4-dichlorogeno-5-fluorobenzoic acids
GEP20074025B (en) Process for preparing acid salts of gemifloxacin
SI1200417T1 (en) Method for preparing 2-(2-arylmorpholin-2-yl)ethanol derivatives and intermediates
AU3181600A (en) 2'-substituted rna preparation
WO2000037469A3 (en) Process for preparing n6-substituted deaza-adenosine derivatives
AU4757000A (en) Method of producing methoxyimino acetic amide
AU2000227880A1 (en) Process for producing batches of rubber-based composition
AU5925498A (en) Processes for producing 3-cyanopyridine from 2-methyl-1,5-pentanediamine
ECSP993123A (es) Procedimiento para preparar sales de trovafloxacina de adicion de acidos